Two cases of biopsy-proven ulcerative colitis are described, and both developed a leucoerythroblastic anaemia during the course of the acute illness. Despite intensive investigation for the presence of bone marrow infiltration, no neoplasm was demonstrated. The leucoerythroblastic anaemia remitted in each case on medical treatment of the ulcerative colitis. The possible mechanisms underlying the development of reversible leucoerythroblastic anaemia are discussed.
Summary
Two cases of biopsy-proven ulcerative colitis are described, and both developed a leucoerythroblastic anaemia during the course of the acute illness. Despite intensive investigation for the presence of bone marrow infiltration, no neoplasm was demonstrated. The leucoerythroblastic anaemia remitted in each case on medical treatment of the ulcerative colitis. The possible mechanisms underlying the development of reversible leucoerythroblastic anaemia are discussed.
Case reports
A 58-year-old woman gave a six-month history of progressive anaemia, lethargy, increased stool frequency with watery diarrhoea and for 6 weeks had noticed rectal blood loss on defaecation. There was no weight loss, no other systematic symptoms and no family history of inflammatory bowel disease.
On examination she was markedly pale with mild bilateral pitting ankle oedema. Abdominal examination was unremarkable but sigmoidoscopy revealed a friable, granular mucosa with contact bleeding and a moderate amount of blood in the bowel lumen. Rectal biopsy showed changes of acute ulcerative colitis.
A blood count on presentation revealed a leucerythroblastic anaemia-(haemoglobin (Hb) The leucoerythroblastic features remitted on medical treatment for her ulcerative colitis. At present she is well, Hb 14 1 g/dl, WCC 5.3x 109/litre with a normal differential count.
Discussion
The term leucoerythroblastic anaemia was first coined by Vaughan (1936) and describes the presence in the peripheral blood of nucleated red cells and immature cells of the neutrophil myeloid series. The major textbooks (Wintrobe et al., 1975; De Gruchy, 1978; Hoffbrand and Lewis, 1981) have given prominence to the neoplastic causes of a leucoerythroblastic anaemia, whereas several studies (Burrett, Cox and Fields, 1965; Werck, Hageborn and Linman, 1974) have demonstrated that up to half of the conditions underlying a leucoerythroblastic picture are of a benign nature. Leucoerythroblastic anaemia also has been demonstrated in animals (Madewell and Feldman, 1980) . However, there are no reports in the literature of a reversible leucoerythroblastic anaemia occurring in association with ulcerative colitis. Retief (1964) showed that conditions such as acute rheumatic fever and haemorrhagic pancreatitis produce a leucoerythroblastic reaction and commented that the degree of normoblastosis was no guide to the probability of bone marrow infiltration. However, normoblastosis occurring during the course of an illness confers a worse prognosis (Schwartz and Stansbury, 1954) .
The pathological process occurring in the bone marrow in conditions producing a leucoerythroblastic anaemia is uncertain. The earliest speculations included suggestions of a direct stimulus to the bone marrow by invading neoplastic cells (Hill and Duncan, 1941 ), but hyperplasia of the marrow tissue had been noted and an accompanying deficiency of a factor essential for normal haemopoeisis was considered likely. Intramedullary endothelial damage allowing larger immature cells to leak out into the peripheral blood has also been proposed (Hilts and Shaw, 1953) , and a third mechanism suggested that immature cells in abnormal locations may be intravascular and therefore easily washed into the circulating blood (Heck and Hall, 1939) . Mechanisms put forward to explain the severe leucoerythroblastic reactions seen in the presence of localized primary cancer of parenchymal organs included a selective chemotactic effect of toxic substances on an haemopoeitic cell type (Arneth, 1937) , possibly a tumour product (Sonnenfield, 1929) . In a non-infiltrative condition, active bone marrow replaces the marrow fat spaces and extends into the yellow marrow of the long bones. It seems reasonable to postulate that if the stressing stimulus is of a severe nature or occurs as an acute exacerbator of a chronic condition, the marrow will release immature cells into the peripheral blood. Acute infections, haemolysis or persistent blood loss are all examples of such reversible stimuli and once decreased or removed the peripheral blood will soon clear of immature forms.
In longstanding ulcerative colitis the development of a leucoerythroblastic anaemia may be taken to be the manifestation of an occult colonic carcinoma, a well recognized complication of chronic ulcerative colitis (Dawson and Pryse Davies, 1959; Edwards and Truelove, 1964) . In our two cases, no such neoplasm was found and the leucoerythroblastic anaemia remitted entirely with medical treatment directed at the ulcerative colitis. Both have remained well with no recurrence during follow up for over 12 months.
Anaemia occurring in association with ulcerative colitis is commonly secondary to blood loss from inflamed colonic mucosa. Chronic gastrointestinal haemorrhage is not a recognized cause of a leucoerythroblastic anaemia and it is likely that the combined effect of blood loss together with a chronic inflammatory condition unduly stressed the bone marrow. Neither case demonstrated evidence of haemolysis, infection or acute massive haemorrhage.
In addition, neither had received drugs with recognized toxic effects on bone marrow. Patient 1 had received no drugs and Patient 2 had been maintained for 9 months on prednisolone and sodium cromoglycate, and this treatment regime was maintained throughout the recovery period.
These two cases demonstrate bone marrow stress of the 'acute on chronic' type, resulting in the typical changes of a leucoerythroblastic anaemia. The reversible nature of these changes has not been previously described in relationship to ulcerative colitis.
